TipRanks
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
US Market
APUS
Apimeds Pharmaceuticals US, Inc.
RESEARCH TOOLSreports

Apimeds Pharmaceuticals US, Inc. (APUS) Balance Sheet

24 Followers

Apimeds Pharmaceuticals US, Inc. Balance Sheet

Apimeds Pharmaceuticals US, Inc.'s total assets for Q2 2026 were $127.62M, a decrease of -9.63% from the previous quarter. APUS total liabilities were $21.18M for the fiscal quarter, a 44.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 164.18M$ 13.06K$ 422.08K$ 6.17K$ 172.17K
Total Liabilities
$ 10.84M$ 1.37M$ 390.20K$ 719.78K$ 410.65K
Total Equity Gross Minority
$ 153.35M$ -1.36M$ 31.87K$ -713.61K$ -238.48K
Other Metrics
Currency in USD

Apimeds Pharmaceuticals US, Inc. Debt to Assets